tiprankstipranks
Alnylam Pharmaceuticals (DE:DUL)
XETRA:DUL
Germany Market
DUL
Alnylam Pharma
RESEARCH TOOLSreports

Alnylam Pharma (DUL) Balance Sheet

4 Followers

Alnylam Pharma Balance Sheet

Alnylam Pharma's total assets for Q2 2026 were $5.56B, an increase of 8.37% from the previous quarter. DE:DUL total liabilities were $4.20B for the fiscal quarter, a 3.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 4.97B$ 4.24B$ 3.83B$ 3.55B$ 3.64B
Total Liabilities
$ 4.18B$ 4.17B$ 4.05B$ 3.70B$ 3.06B
Total Equity Gross Minority
$ 789.18M$ 67.09M$ -220.64M$ -158.22M$ 588.20M
Other Metrics
Currency in USD

Alnylam Pharma Debt to Assets